To test this hypothesis, a feeding trial was conducted with 53 German Holstein cows, comprising a control group (CON, n = 26) and an L-carnitine supplemented group (CAR, n = 27, 25 g rumen-protected L-carnitine/cow/d)
When examining a composite cardio outcomes endpoint (death from CV disease, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina), the ELIXA trial suggested that GLP-1s did not increase cardiovascular event risk (hazard ratio of 1.02)
SAVE THIS
Preliminary clinical studies suggest CoQ10 (300400 mg/day) improves fatigue and sleep disturbances, but larger trials are needed for confirmation
Biochem J 475:959976 Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, Lim PB, McNarry M, Morten K, OSullivan O, Pretorius E, Raman B, Soteropoulos DS, Taquet M, Hall CN (2023) Long covid: mechanisms, risk factors and recovery